You are here

  • Home
  • Archive
  • Volume 67, Issue 5
  • CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC

Article metrics

Article menu
Download PDFPDF
Commentary
CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC

 

Online download statistics by month:

Online download statistics by month: October 2017 to March 2024

AbstractFullPdf
Oct 20174483222
Nov 20173134531
Dec 20172082212
Jan 20187276
Feb 20187996
Mar 20181692215
Apr 201885312837
May 20186505034
Jun 2018193159
Jul 20181081813
Aug 201810193
Sep 2018135118
Oct 2018902513
Nov 201878107
Dec 2018112207
Jan 20191372018
Feb 20198264
Mar 201910899
Apr 20196844
May 20193041
Jun 20193343
Jul 20198252
Aug 20195595
Sep 20195443
Oct 20194231
Nov 20193531
Dec 20195183
Jan 20204981
Feb 20203304
Mar 20206021
Apr 20206573
May 20206523
Jun 20202411
Jul 20205353
Aug 20204301
Sep 20204552
Oct 20205353
Nov 20208311
Dec 20203444
Jan 20216776
Feb 20215813
Mar 20213822
Apr 20212123
May 20211943
Jun 2021933
Jul 2021500
Aug 20211071
Sep 2021333
Oct 20213732
Nov 202198104
Dec 20215020
Jan 20225720
Feb 2022103135
Mar 20226443
Apr 20227700
May 202214811
Jun 202215323
Jul 202210341
Aug 202210052
Sep 202216962
Oct 202212342
Nov 20224990
Dec 20229232
Jan 202313395
Feb 20237973
Mar 202390114
Apr 20235831
May 20239204
Jun 20234246
Jul 20235043
Aug 20239832
Sep 20237071
Oct 20233540
Nov 20232674
Dec 20233800
Jan 20243524
Feb 20242921
Mar 20244064
Total7561708397